Status:
COMPLETED
Navrongo Drug Options for IPT in Pregnancy Trial
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborating Sponsors:
Ministry of Health, Ghana
Conditions:
Malaria
Eligibility:
FEMALE
15-45 years
Phase:
PHASE2
PHASE3
Brief Summary
In areas of stable transmission, pregnant women, especially during the first and second pregnancies, have an increased susceptibility to Plasmodium falciparum malaria, malaria-related anaemia and an i...
Detailed Description
Background Pregnant women, particularly during the first and second pregnancy, have a high risk of Plasmodium falciparum infection and these infections are often asymptomatic but lead to maternal anae...
Eligibility Criteria
Inclusion
- Pregnant women with gestation between 18-32weeks,
- willing to give written consent to take part in the study
- Resident in the study area and available for follow-up.
Exclusion
- Presentation with clinical symptoms of malaria (this would not affect subsequent enrollment at a later date),
- Known allergies or reactions to study drugs,
- Medical conditions needing hospital admission.
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
3642 Patients enrolled
Trial Details
Trial ID
NCT00146783
Start Date
June 1 2004
End Date
February 1 2007
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Navrongo District Hosptial
Navrongo, Upper East Region, Ghana